Padeliporfin Active Not Recruiting Phase 2 Trials for Localized Prostate Cancer Treatment

Back to Padeliporfin
IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03315754
Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.